Literature DB >> 12452392

A review of achalasia in 33 children.

Sunny Zaheed Hussain1, Ronald Thomas, Vasundhara Tolia.   

Abstract

We reviewed our experience in the diagnosis and management of esophageal achalasia in 33 children over a 25-year period at a single center by a retrospective chart review of all patients diagnosed with achalasia between December 1, 1975 and January 30, 2001. There were 33 cases ranging from 5 months to 16 years of age at the time of presentation (17 boys and 16 girls). Although dysphagia and vomiting were the commonest presenting symptoms, weight loss, chest pain, coughing, and recurrent pneumonia also occurred in many patients. Barium contrast study of the esophagus was the initial diagnostic modality followed by esophageal manometry. An upper endoscopy was also performed in 78.7% of cases. Management was predominantly surgical; however, seven recently diagnosed patients opted for botulinum toxin (botox) injection as the first line of treatment. The follow-up duration varied from 10 months to 10 years (mean 4.71 +/- 3.2 years). Postsurgical complications included gastroesophageal reflux disease in five patients who had not received a simultaneous antireflux procedure and "residual achalasia" in two patients, who both responded to a single botox injection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452392     DOI: 10.1023/a:1020572328777

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

Review 1.  Gastrointestinal uses of botulinum toxin.

Authors:  M S Bhutani
Journal:  Am J Gastroenterol       Date:  1997-06       Impact factor: 10.864

2.  Risk factors for diagnostic delay in achalasia.

Authors:  V F Eckardt; U Köhne; T Junginger; T Westermeier
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

3.  Epidemiological study of achalasia in children.

Authors:  J F Mayberry; M J Mayell
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

4.  Histopathologic features in esophagomyotomy specimens from patients with achalasia.

Authors:  J R Goldblum; T W Rice; J E Richter
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

Review 5.  Esophageal motility disorders: current concepts of pathogenesis and treatment.

Authors:  P J Kahrilas
Journal:  Can J Gastroenterol       Date:  2000-03       Impact factor: 3.522

6.  The use of nifedipine for the treatment of achalasia in children.

Authors:  M Maksimak; D H Perlmutter; H S Winter
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 Nov-Dec       Impact factor: 2.839

Review 7.  Current therapies for achalasia: comparison and efficacy.

Authors:  M F Vaezi; J E Richter
Journal:  J Clin Gastroenterol       Date:  1998-07       Impact factor: 3.062

8.  Difficulties in the diagnosis of pseudoachalasia.

Authors:  J P Tracey; M Traube
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

9.  Achalasia in three siblings: a rare occurrence.

Authors:  F A London; D E Raab; J Fuller
Journal:  Mayo Clin Proc       Date:  1977-02       Impact factor: 7.616

10.  Achalasia in childhood: a 20-year experience.

Authors:  R G Azizkhan; D Tapper; A Eraklis
Journal:  J Pediatr Surg       Date:  1980-08       Impact factor: 2.545

View more
  17 in total

1.  Outcomes of treatment of childhood achalasia.

Authors:  Constance W Lee; David W Kays; Mike K Chen; Saleem Islam
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

2.  Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children.

Authors:  Ricardo A Arbizu; Leonel Rodriguez
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

3.  Long-term outcomes of Heller's myotomy and balloon dilatation in childhood achalasia.

Authors:  Efstratios Saliakellis; Nikhil Thapar; Derek Roebuck; Fernanda Cristofori; Kate Cross; Edward Kiely; Joseph Curry; Keith Lindley; Osvaldo Borrelli
Journal:  Eur J Pediatr       Date:  2017-05-23       Impact factor: 3.183

4.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

5.  Gastrointestinal motility disorders in children.

Authors:  Lusine Ambartsumyan; Leonel Rodriguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

6.  Pediatric gastrointestinal motility disorders: challenges and a clinical update.

Authors:  Bruno Chumpitazi; Samuel Nurko
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-02

7.  Diagnosis and management of esophageal achalasia in children: analysis of 13 cases.

Authors:  Yin Zhang; Chun-Di Xu; Abdehaman Zaouche; Wei Cai
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

8.  How robotic-assisted surgery can decrease the risk of mucosal tear during Heller myotomy procedure?

Authors:  Quentin Ballouhey; Nabil Dib; Aurélien Binet; Véronique Carcauzon-Couvrat; Pauline Clermidi; Bernard Longis; Hubert Lardy; Jane Languepin; Jérôme Cros; Laurent Fourcade
Journal:  J Robot Surg       Date:  2016-11-07

Review 9.  Childhood achalasia: A comprehensive review of disease, diagnosis and therapeutic management.

Authors:  Ashanti L Franklin; Mikael Petrosyan; Timothy D Kane
Journal:  World J Gastrointest Endosc       Date:  2014-04-16

10.  Achalasia Cardia in a Young Infant.

Authors:  V Poornachand; K Kumarasamy; S P Karamath; V Seenivasan; Sumathi Bavanandam; Nirmala Dheivamani
Journal:  Indian J Pediatr       Date:  2018-01-17       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.